4//SEC Filing
JONAS JEFFREY M 4
Accession 0000950170-23-037379
CIK 0001771917other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:53 PM ET
Size
15.2 KB
Accession
0000950170-23-037379
Insider Transaction Report
Form 4
JONAS JEFFREY M
Director
Transactions
- Exercise/Conversion
Common Stock
2023-08-01$7.27/sh+13,810$100,399→ 14,800 total - Sale
Common Stock
2023-08-01$194.78/sh−3,399$662,057→ 11,401 total - Sale
Common Stock
2023-08-01$197.66/sh−400$79,064→ 1,590 total - Sale
Common Stock
2023-08-01$196.59/sh−3,110$611,395→ 1,990 total - Sale
Common Stock
2023-08-01$198.41/sh−600$119,046→ 990 total - Sale
Common Stock
2023-08-01$195.61/sh−6,301$1,232,539→ 5,100 total - Exercise/Conversion
Option (right to buy)
2023-08-01−13,810→ 33,702 totalExercise: $7.27Exp: 2028-09-30→ Common Stock (13,810 underlying)
Footnotes (7)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.11 to $195.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (6) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.11 to $196.08, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.11 to $197.07, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.12 to $198.08, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.18 to $198.58, inclusive.
- [F7]This option vested and became exercisable in eight equal installments on each six month anniversary of the vesting commencement date of September 20, 2018.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001042021
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:53 PM ET
- Size
- 15.2 KB